Cargando…
Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry
The current situation in Iran suggests an appropriate basis for developing biotechnology industries, because the patents for the majority of hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies which do not have patents will have the opportunit...
Autores principales: | Emami, Hassan, Radfar, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610777/ https://www.ncbi.nlm.nih.gov/pubmed/29201110 |
Ejemplares similares
-
Nonclinical statistics for pharmaceutical and biotechnology industries
por: Zhang, Lanju
Publicado: (2016) -
Biotechnological applications of functional metagenomics in the food and pharmaceutical industries
por: Coughlan, Laura M., et al.
Publicado: (2015) -
Pharmaceutical biotechnology
Publicado: (1995) -
Pharmaceutical biotechnology
por: Metcalf, Brian, et al.
Publicado: (2003) -
Pharmaceutical Biotechnology
por: Roque-Borda, Cesar Augusto, et al.
Publicado: (2022)